search button

Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia

  • Authors:
    • Shi‑Guang Ye
    • Yi Ding
    • Liang Li
    • Meng Yang
    • Wen‑Jun Zhang
    • Ai‑Bin Liang

  • View Affiliations

  • Published online on: March 6, 2015     https://doi.org/10.3892/mco.2015.527
  • Pages: 730-736
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Colony‑stimulating factors (CSF) have been widely used to prevent febrile neutropenia associated with chemotherapy. Due to the high intensity of chemotherapy in acute lymphoblastic leukemia (ALL), CSF as a crucial component of supportive care has played a significant role in the therapy. However, the effectiveness of CSF in treatment has not been identified by large clinical trials until now. The aim of the present study was to evaluate the effect of CSF on the long‑term outcome of adult ALL patients. A comprehensive search strategy has been conducted, which covered the Cochrane Central Register of Controlled Trials, PubMed and Web of Science. The result includes seven randomized controlled trials containing a total of 753 patients. The administration of CSF significantly reduced the mortality at the end of the follow‑up (RR, 0.85; 95% CI, 0.75‑0.95), the mortality at day 30 (RR, 0.41; 95% CI, 0.23‑0.74) and the number of patients with infection or severe infections (RR, 0.8; 95% CI, 0.7‑0.9 and RR, 0.48; 95% CI, 0.3‑0.75). The addition of CSF also marginally increased the number of patients achieving CR (RR, 1.14; 95% CI, 1.05‑1.23). The use of CSF also shortened the duration of neutropenia (median days, 8‑17 to 12.5‑24). In conclusion, CSFs can be administered to ALL patients during myelosuppressive chemotherapy, particularly in the induction phase.
View Figures
View References

Related Articles

Journal Cover

May-2015
Volume 3 Issue 3

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 1.4
  • Ranked
    (total number of cites)
  • CiteScore: 2.8
  • CiteScore Rank: Q3: #250/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.55
  • SCImago Journal Rank (SJR): 0.446
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Ye SG, Ding Y, Li L, Yang M, Zhang WJ and Liang AB: Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia. Mol Clin Oncol 3: 730-736, 2015.
APA
Ye, S., Ding, Y., Li, L., Yang, M., Zhang, W., & Liang, A. (2015). Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia. Molecular and Clinical Oncology, 3, 730-736. https://doi.org/10.3892/mco.2015.527
MLA
Ye, S., Ding, Y., Li, L., Yang, M., Zhang, W., Liang, A."Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia". Molecular and Clinical Oncology 3.3 (2015): 730-736.
Chicago
Ye, S., Ding, Y., Li, L., Yang, M., Zhang, W., Liang, A."Colony-stimulating factors for chemotherapy-related febrile neutropenia are associated with improved prognosis in adult acute lymphoblastic leukemia". Molecular and Clinical Oncology 3, no. 3 (2015): 730-736. https://doi.org/10.3892/mco.2015.527